Hopkins Craig Douglas

CEO Hopkins Craig Douglas bought 10,000 shares of BRN at $1.65; prior BRN buys both underperformed 90-day mark, company unprofitable.

Hopkins Craig Douglas, Chief Executive Officer, purchased 10,000 shares at $1.65 on 2025-01-17, increasing his holdings from 141,000 to 151,000 shares. His two prior purchases at BRN (on 2024-08-29 and 2024-08-28) both declined over the 90-day period, with losses of -29.2% and -27.0% respectively; neither trade was well-timed at the 90-day mark. The company's latest quarterly revenue was $5.5M with net income of $-1.2M, and annual revenue contracted -14.0% year-over-year while the firm remains unprofitable. The current price of $1.65 sits 44.1% below the 52-week high of $2.95, though up 15.4% over the past 30 days.

BRN President/CEO buys 10,000 shares across 2 transactions for $24,349.50; company unprofitable, -11.5% annual revenue growth

Hopkins Craig Douglas, President and CEO, purchased 10,000 shares in 2 separate transactions on 2024-08-28 and 2024-08-29 at blended average price of $2.43, increasing his holdings from 65,000 shares to 75,000 shares (+15.4%). The purchase occurs within the 52-week range ($2.17–$2.95) and near current price of $2.44. However, material financial headwinds characterize the company: net income was $-1,246,000.00 (negative), latest quarterly revenue is $5,527,000.00 with annual revenue declining -11.5% year-over-year, and the company was unprofitable over its most recent full fiscal year. The insider's acquisition of a 15.4% increase in holdings during a period of financial deterioration warrants scrutiny regarding motivation—particularly whether this represents conviction in a recovery scenario or reflects alternative strategic considerations not evident in public fundamentals.